Global Retirement Partners’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$118K Buy
7,039
+4,593
+188% +$77.2K ﹤0.01% 1810
2025
Q3
$37.9K Buy
2,446
+71
+3% +$972 ﹤0.01% 2061
2025
Q2
$30.4K Buy
+2,375
New +$29.3K ﹤0.01% 2055
2024
Q4
$28.1K Hold
2,140
﹤0.01% 1899
2024
Q3
$32.3K Buy
2,140
+66
+3% +$999 ﹤0.01% 1761
2024
Q2
$29.4K Sell
2,074
-3,302
-61% -$44.7K ﹤0.01% 1804
2024
Q1
$73.3K Buy
5,376
+151
+3% +$2.09K ﹤0.01% 1226
2023
Q4
$73.5K Buy
5,225
+115
+2% +$1.42K ﹤0.01% 1191
2023
Q3
$62.6K Buy
5,110
+127
+3% +$1.67K ﹤0.01% 1160
2023
Q2
$67.5K Buy
4,983
+111
+2% +$1.53K ﹤0.01% 1128
2023
Q1
$67.6K Buy
4,872
+116
+2% +$1.66K ﹤0.01% 1102
2022
Q4
$67.6K Buy
4,756
+97
+2% +$1.41K ﹤0.01% 967
2022
Q3
$68K Buy
4,659
+102
+2% +$1.52K 0.01% 902
2022
Q2
$65K Buy
4,557
+111
+2% +$1.68K 0.01% 895
2022
Q1
$65K Buy
+4,446
New +$76.5K 0.01% 889
2021
Q4
Sell
-1,586
Closed -$33K 912
2021
Q3
$33K Buy
1,586
+31
+2% +$664 ﹤0.01% 1012
2021
Q2
$33K Buy
1,555
+29
+2% +$585 ﹤0.01% 1017
2021
Q1
$30K Buy
+1,526
New +$31.4K ﹤0.01% 973

Other funds holding HQL

Global Retirement Partners's HQL Position: Q4 2025 in Review

Global Retirement Partners increased its abrdn Life Sciences Investors (HQL) stake by 188% in Q4 2025, buying an estimated $77.2K and bringing the position to 7,039 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #1810.

Global Retirement Partners first reported a position in HQL in Q1 2021 and has held it in 18 quarters since. 73 funds tracked by Wall St. Rank hold HQL as of Q4 2025.

  • Global Retirement Partners held 7,039 shares of abrdn Life Sciences Investors worth $118K as of Q4 2025.
  • Global Retirement Partners bought 4,593 abrdn Life Sciences Investors shares in Q4 2025, an estimated $77.2K.
  • abrdn Life Sciences Investors made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #1810 holding.
  • Global Retirement Partners first reported a position in abrdn Life Sciences Investors in Q1 2021 and has held it in 18 quarters since.
  • 73 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.